Skip to main content
Nikolaos Trikalinos, MD, Oncology, Florissant, MO, Siteman Cancer Center

NikolaosTrikalinosMD

Oncology Florissant, MO

Physician

Dr. Trikalinos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Trikalinos' full profile

Already have an account?

Education & Training

  • John Hopkins University
    John Hopkins UniversityMaster's, Regulatory Science, 2016
  • University of Maryland
    University of MarylandFellowship, Hematology and Medical Oncology, 2011 - 2014
  • MetroWest Medical Center
    MetroWest Medical CenterResidency, Internal Medicine, 2007 - 2011
  • University of Ioannina Faculty of Medicine
    University of Ioannina Faculty of MedicineClass of 2005

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2020 - 2026
  • MO State Medical License
    MO State Medical License 2017 - 2025
  • MD State Medical License
    MD State Medical License 2014 - 2017
  • MA State Medical License
    MA State Medical License 2010 - 2013
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Excellence in Research Award US Oncology Network, 2015
  • Outstanding Performance Award Metrowest Medical Center, 2011
  • Compliance Award, Outstanding Documentation University of Maryland, 2011
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • FOLFIRINOX for the Treatment of Advanced Gastroesophageal Cancers  
    Haeseong Park, Andrea Wang-Gillam, Caron Rigden, Katrina S Pedersen, Nikolaos A Trikalinos, JAMA Oncology
  • Socioeconomic status and survival in glioblastoma  
    Trikalinos NA, Goloubeva O, Mehta MP, Kwok Y, Sausville E, Int J Clin Exp Med, 1/1/2016
  • International ranking systems for universities and institutions: a critical appraisal  
    Ioannidis JP, et al, BMC Med, 1/25/2007

Abstracts/Posters

  • Preoperative monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio are associated with overall survival after resection of pancreatic neuroendocrine tumors.
    Roheena Z. Panni, Bradley Krasnick, Jesse Davidson, Alexandra G. Lopez-Aguiar, Eleftherios Makris, George Poultsides, Zaheer Kanji, Flavio Rocha, Alexander V. Fisher, ..., Gastrointestinal Cancers Symposium, 1/1/2018
  • A phase II trial of first-line FOLFIRINOX for patients with advanced gastroesophageal adenocarcinoma.
    Haeseong Park, Andrea Wang-Gillam, Rama Suresh, Caron E. Rigden, Manik A. Amin, Benjamin R. Tan Jr., Katrina Pedersen, Kian-Huat Lim, Nikolaos Trikalinos, Katherine Na..., Gastrointestinal Cancers Symposium, 1/1/2018
  • Grade switch and survival in a cohort of 95 resected pancreatic neuroendocrine neoplasms (PanNEN).
    Nikolaos A Trikalinos, Chet Hammill, Gregory Williams, Jingxia Liu, William Hawkins and Deyali Chatterjee, North American Neuroendocrine Tumors Society Symposium, 1/1/2018
  • Join now to see all

Lectures

  • Colorectal cancer. 
    1/12/2018

Other

  • Assessing the Accuracy of Google Translate To Allow Data Extraction From Trials. 
    Balk, et al, AHRQ Methods Research Report

Authored Content

  • FOLFIRINOX for the Treatment of Advanced Gastroesophageal CancersMay 2020

Press Mentions

  • Siteman Cancer Center to Open North St. Louis County Location July 1
    Siteman Cancer Center to Open North St. Louis County Location July 1June 30th, 2017

Hospital Affiliations